IL1B and atopic eczema: Astragalin is associated with various pharmacological and biological activities, including anti-inflammatory, antioxidant activity, anti-atopic dermatitis activity, TNF-a, IL-1b, and IL-6 production inhibiting activity, and inhibiting histamine release in human blood cells (Riaz et al., 2018).